FFA
DFTX icon

Farther Finance Advisors’s Definium Therapeutics DFTX Stock Holding History

Farther Finance Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$470K Buy
12,338
+11,176
+962% +$471K ﹤0.01% 1639
2026
Q2 		$54.7K Buy
1,162
+595
+105% +$14.7K ﹤0.01% 3187
2026
Q1 		$11.7K Buy
567
+110
+24% +$1.87K ﹤0.01% 3999
2025
Q4 		$6.12K Hold
457
– – ﹤0.01% 4193
2025
Q3 		$5.39K Hold
457
– – ﹤0.01% 3727
2025
Q2 		$2.97K Sell
457
-537
-54% -$3.53K ﹤0.01% 3561
2025
Q1 		$5.51K Buy
994
+93
+10% +$666 ﹤0.01% 3012
2024
Q4 		$6.27K Sell
901
-20
-2% -$138 ﹤0.01% 2570
2024
Q3 		$5.24K Buy
921
+821
+821% +$5.71K ﹤0.01% 2627
2024
Q2 		$707 Hold
100
– – ﹤0.01% 3181
2024
Q1 		$952 Hold
100
– – ﹤0.01% 2799
2023
Q4 		$366 Hold
100
– – ﹤0.01% 3075
2023
Q3 		$313 Hold
100
– – ﹤0.01% 2372
2023
Q2 		$357 Hold
100
– – ﹤0.01% 2240
2023
Q1 		$317 Buy
+100
New +$332 ﹤0.01% 2111

Other funds holding DFTX

SCI
Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BWM
Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's DFTX Position: Q3 2026 in Review

Farther Finance Advisors increased its Definium Therapeutics (DFTX) stake by 962% in Q3 2026, buying an estimated $471K and bringing the position to 12,338 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Farther Finance Advisors first reported a position in DFTX in Q1 2023 and has held it in 15 quarters since. 8 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Farther Finance Advisors held 12,338 shares of Definium Therapeutics worth $470K as of Q3 2026.
  • Farther Finance Advisors bought 11,176 Definium Therapeutics shares in Q3 2026, an estimated $471K.
  • Definium Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1639 holding.
  • Farther Finance Advisors first reported a position in Definium Therapeutics in Q1 2023 and has held it in 15 quarters since.
  • 8 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.